BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BMY - US1101221083 - Common Stock
46.045 EUR
-0.78 (-1.68%)
Taking everything into account, 1BMY scores 6 out of 10 in our fundamental rating. 1BMY was compared to 54 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of 1BMY get a neutral evaluation. Nothing too spectacular is happening here. 1BMY is valued quite cheap, while showing a decent growth score. This is a good combination! Finally 1BMY also has an excellent dividend rating. These ratings would make 1BMY suitable for value and dividend investing!
1. Profitability
1.1 Basic Checks
- 1BMY had positive earnings in the past year.
- In the past year 1BMY had a positive cash flow from operations.
- In multiple years 1BMY reported negative net income over the last 5 years.
- In the past 5 years 1BMY always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of 6.23%, 1BMY perfoms like the industry average, outperforming 53.70% of the companies in the same industry.
- 1BMY has a Return On Equity of 32.55%. This is in the better half of the industry: 1BMY outperforms 79.63% of its industry peers.
- 1BMY has a Return On Invested Capital of 17.49%. This is in the better half of the industry: 1BMY outperforms 79.63% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for 1BMY is below the industry average of 13.93%.
- The 3 year average ROIC (11.67%) for 1BMY is below the current ROIC(17.49%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 17.49% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
1.3 Margins
- 1BMY's Profit Margin of 12.57% is in line compared to the rest of the industry. 1BMY outperforms 50.00% of its industry peers.
- 1BMY has a better Operating Margin (33.51%) than 81.48% of its industry peers.
- In the last couple of years the Operating Margin of 1BMY has declined.
- 1BMY has a Gross Margin (73.15%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of 1BMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
- The number of shares outstanding for 1BMY has been reduced compared to 1 year ago.
- 1BMY has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for 1BMY is higher compared to a year ago.
2.2 Solvency
- 1BMY has an Altman-Z score of 2.24. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
- 1BMY has a Altman-Z score of 2.24. This is comparable to the rest of the industry: 1BMY outperforms 46.30% of its industry peers.
- The Debt to FCF ratio of 1BMY is 3.20, which is a good value as it means it would take 1BMY, 3.20 years of fcf income to pay off all of its debts.
- 1BMY has a Debt to FCF ratio of 3.20. This is in the better half of the industry: 1BMY outperforms 68.52% of its industry peers.
- 1BMY has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
- 1BMY's Debt to Equity ratio of 2.41 is on the low side compared to the rest of the industry. 1BMY is outperformed by 79.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.24 |
ROIC/WACC2.03
WACC8.61%
2.3 Liquidity
- A Current Ratio of 1.27 indicates that 1BMY should not have too much problems paying its short term obligations.
- 1BMY has a Current ratio of 1.27. This is comparable to the rest of the industry: 1BMY outperforms 40.74% of its industry peers.
- 1BMY has a Quick Ratio of 1.17. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.17, 1BMY is in the better half of the industry, outperforming 68.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
- 1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 460.68%, which is quite impressive.
- The earnings per share for 1BMY have been decreasing by -24.57% on average. This is quite bad
- 1BMY shows a small growth in Revenue. In the last year, the Revenue has grown by 1.26%.
- Measured over the past years, 1BMY shows a quite strong growth in Revenue. The Revenue has been growing by 13.06% on average per year.
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
3.2 Future
- The Earnings Per Share is expected to grow by 35.26% on average over the next years. This is a very strong growth
- Based on estimates for the next years, 1BMY will show a decrease in Revenue. The Revenue will decrease by -4.97% on average per year.
EPS Next Y479.55%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
EPS Next 5Y35.26%
Revenue Next Year0.19%
Revenue Next 2Y-4.06%
Revenue Next 3Y-3.05%
Revenue Next 5Y-4.97%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.24, the valuation of 1BMY can be described as very reasonable.
- Based on the Price/Earnings ratio, 1BMY is valued cheaper than 88.89% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.32, 1BMY is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 8.86, the valuation of 1BMY can be described as reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 88.89% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.30, 1BMY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.24 | ||
| Fwd PE | 8.86 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1BMY is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 98.15% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.18 | ||
| EV/EBITDA | 6.82 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- 1BMY's earnings are expected to grow with 73.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y131.22%
EPS Next 3Y73.98%
5. Dividend
5.1 Amount
- 1BMY has a Yearly Dividend Yield of 4.77%, which is a nice return.
- Compared to an average industry Dividend Yield of 1.59, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 92.59% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.86, 1BMY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.77% |
5.2 History
- The dividend of 1BMY is nicely growing with an annual growth rate of 11.67%!
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1BMY pays out 82.81% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of 1BMY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP82.81%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
BIT:1BMY (1/21/2026, 7:00:00 PM)
46.045
-0.78 (-1.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-05 2026-02-05/amc
Inst Owners81.74%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap93.74B
Revenue(TTM)48.03B
Net Income(TTM)6.04B
Analysts67.65
Price Target45.28 (-1.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.77% |
Yearly Dividend2.07
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)2.04%
PT rev (3m)-2%
EPS NQ rev (1m)5.31%
EPS NQ rev (3m)4.49%
EPS NY rev (1m)0.33%
EPS NY rev (3m)0.41%
Revenue NQ rev (1m)1.98%
Revenue NQ rev (3m)2.19%
Revenue NY rev (1m)1.32%
Revenue NY rev (3m)1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.24 | ||
| Fwd PE | 8.86 | ||
| P/S | 2.29 | ||
| P/FCF | 7.18 | ||
| P/OCF | 6.61 | ||
| P/B | 5.93 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.82 |
EPS(TTM)5.59
EY12.14%
EPS(NY)5.2
Fwd EY11.29%
FCF(TTM)6.41
FCFY13.92%
OCF(TTM)6.96
OCFY15.12%
SpS20.12
BVpS7.77
TBVpS-9.91
PEG (NY)0.02
PEG (5Y)N/A
Graham Number31.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROCE | 23.41% | ||
| ROIC | 17.49% | ||
| ROICexc | 22.99% | ||
| ROICexgc | 117.18% | ||
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% | ||
| FCFM | 31.86% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
ROICexc(3y)13.73%
ROICexc(5y)11.71%
ROICexgc(3y)74.95%
ROICexgc(5y)76.74%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Debt/EBITDA | 2.13 | ||
| Cap/Depr | 26.84% | ||
| Cap/Sales | 2.75% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 79.11% | ||
| Profit Quality | 253.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.24 |
F-Score6
WACC8.61%
ROIC/WACC2.03
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
EPS Next Y479.55%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
EPS Next 5Y35.26%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
Revenue Next Year0.19%
Revenue Next 2Y-4.06%
Revenue Next 3Y-3.05%
Revenue Next 5Y-4.97%
EBIT growth 1Y44.7%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year262.1%
EBIT Next 3Y50.55%
EBIT Next 5Y23.19%
FCF growth 1Y30.91%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y28.71%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.
Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 5 / 10.
Can you provide the financial health for 1BMY stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.
Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 8 / 10 and the dividend payout ratio is 82.81%.